Summary
Zhengwei Xie is an associate professor and entrepreneur with nine years of experience at the intersection of aging biology and AI-driven drug discovery. Based at Peking University and the International Cancer Institute in Haidian, he leads a lab focused on anti-aging pharmacology and investigates molecular mechanisms of aging informed by earlier yeast-rejuvenation research. As founder of GigaCeuticals, he applies AI to identify patentable drug functions, bridging academic rigor with product-focused innovation. His background spans a PhD in molecular aging, a formative exchange at UCSF, and multidisciplinary undergraduate training in chemistry, physics, and biology, which fuels a systems-level approach to translational therapeutics. Notably, he sustains concurrent academic leadership and startup growth, signaling an uncommon blend of bench science and biotech entrepreneurship.
9 years of coding experience
BS, Chemistry, Physics and Biology, BS, Chemistry, Physics and Biology at Nanjing University
PhD, Molecular mechanisms of aging, PhD, Molecular mechanisms of aging at Peking University
Chinese, English